Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study.
Saved in:
| Title: | Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study. |
|---|---|
| Authors: | Yimer H; Texas Oncology-Tyler/US Oncology Research, Tyler, TX, USA., Melear J; US Oncology Research, Texas Oncology - Austin Midtown, Austin, TX, USA., Faber E; Oncology Hematology Care, Cincinnati, OH, USA., Bensinger WI; Myeloma & Transplant Program, Swedish Cancer Institute, Seattle, WA, USA., Burke JM; US Oncology Research, Rocky Mountain Cancer Centers, Aurora, CO, USA., Narang M; US Oncology Research, Maryland Oncology Hematology, P.A., Columbia, MD, USA., Stevens D; Norton Cancer Institute, Louisville, KY, USA., Gunawardena S; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Lutska Y; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Qi K; Janssen Research & Development, LLC, Titusville, NJ, USA., Ukropec J; Janssen Global Medical Affairs, Horsham, PA, USA., Qi M; Janssen Research & Development, LLC, Spring House, PA, USA., Lin TS; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Rifkin RM; US Oncology Research, Rocky Mountain Cancer Centers, Denver, CO, USA. |
| Source: | British journal of haematology [Br J Haematol] 2019 May; Vol. 185 (3), pp. 492-502. Date of Electronic Publication: 2019 Mar 03. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30828799 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yimer+H%22">Yimer H</searchLink>; Texas Oncology-Tyler/US Oncology Research, Tyler, TX, USA.<br /><searchLink fieldCode="AU" term="%22Melear+J%22">Melear J</searchLink>; US Oncology Research, Texas Oncology - Austin Midtown, Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Faber+E%22">Faber E</searchLink>; Oncology Hematology Care, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Bensinger+WI%22">Bensinger WI</searchLink>; Myeloma & Transplant Program, Swedish Cancer Institute, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Burke+JM%22">Burke JM</searchLink>; US Oncology Research, Rocky Mountain Cancer Centers, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Narang+M%22">Narang M</searchLink>; US Oncology Research, Maryland Oncology Hematology, P.A., Columbia, MD, USA.<br /><searchLink fieldCode="AU" term="%22Stevens+D%22">Stevens D</searchLink>; Norton Cancer Institute, Louisville, KY, USA.<br /><searchLink fieldCode="AU" term="%22Gunawardena+S%22">Gunawardena S</searchLink>; Janssen Scientific Affairs, LLC, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lutska+Y%22">Lutska Y</searchLink>; Janssen Scientific Affairs, LLC, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Qi+K%22">Qi K</searchLink>; Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Ukropec+J%22">Ukropec J</searchLink>; Janssen Global Medical Affairs, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Qi+M%22">Qi M</searchLink>; Janssen Research & Development, LLC, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+TS%22">Lin TS</searchLink>; Janssen Scientific Affairs, LLC, Horsham, PA, USA.<br /><searchLink fieldCode="AU" term="%22Rifkin+RM%22">Rifkin RM</searchLink>; US Oncology Research, Rocky Mountain Cancer Centers, Denver, CO, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2019 May; Vol. 185 (3), pp. 492-502. <i>Date of Electronic Publication: </i>2019 Mar 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30828799 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.15806 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 492 Titles: – TitleFull: Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yimer H – PersonEntity: Name: NameFull: Melear J – PersonEntity: Name: NameFull: Faber E – PersonEntity: Name: NameFull: Bensinger WI – PersonEntity: Name: NameFull: Burke JM – PersonEntity: Name: NameFull: Narang M – PersonEntity: Name: NameFull: Stevens D – PersonEntity: Name: NameFull: Gunawardena S – PersonEntity: Name: NameFull: Lutska Y – PersonEntity: Name: NameFull: Qi K – PersonEntity: Name: NameFull: Ukropec J – PersonEntity: Name: NameFull: Qi M – PersonEntity: Name: NameFull: Lin TS – PersonEntity: Name: NameFull: Rifkin RM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2019 May Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 185 – Type: issue Value: 3 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |